Evidence map›Paper›PMID 34375587›Full record

ArticleAmerican journal of human genetics2021

Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.

Jacob R Stolz, Kendall M Foote, Hermine E Veenstra-Knol, Rolph Pfundt, Sanne W Ten Broeke, Nicole de Leeuw, Laura Roht, Sander Pajusalu, Reelika Part, Ionella Rebane and 29 more

Erratum issuedOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Activation of kainate receptor GluK2-Neto2 complex.Nature structural & molecular biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Structure and gating of kainate receptors.Frontiers in pharmacology · 2025
    Review
  11. Article
  12. Article
  13. A novel AAV9-dual microRNA-vector targetingMolecular therapy. Methods & clinical development · 2024
    Article
  14. Decoding the genetic landscape of autism: A comprehensive review.World journal of clinical pediatrics · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 18 institutions in 7 countries.

Jacob R StolzDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Kendall M FooteDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Hermine E Veenstra-KnolDepartment of Genetics, University Medical Center Groningen, Groningen 9700, the Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen 6525, the Netherlands.
Sanne W Ten BroekeDepartment of Genetics, University Medical Center Groningen, Groningen 9700, the Netherlands.
Nicole de LeeuwDepartment of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen 6525, the Netherlands.
Laura RohtDepartment of Clinical Genetics, Tartu University Hospital, Tartu 50406, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, Tartu University, Tartu 51003, Estonia.
Sander PajusaluDepartment of Clinical Genetics, Tartu University Hospital, Tartu 50406, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, Tartu University, Tartu 51003, Estonia.
Reelika PartDepartment of Neonatal and Infant Medicine, Tallinn Children's Hospital, Tallinn 13419, Estonia.
Ionella RebaneDepartment of Neonatal and Infant Medicine, Tallinn Children's Hospital, Tallinn 13419, Estonia.
Katrin ÕunapDepartment of Clinical Genetics, Tartu University Hospital, Tartu 50406, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, Tartu University, Tartu 51003, Estonia.
Zornitza StarkMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Australian Genomics Health Alliance, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Edwin P KirkSchool of Women's and Children's Health, UNSW Medicine, University of New South Wales, Randwick, NSW 2031, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, NSW 2031, Australia.
John A LawsonDepartment of Neurology, Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Sebastian LunkeMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Australian Genomics Health Alliance, Melbourne, VIC 3052, Australia.
John ChristodoulouMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Australian Genomics Health Alliance, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Raymond J LouieGreenwood Genetic Center, Greenwood, SC 29646, USA.
R Curtis RogersGreenwood Genetic Center, Greenwood, SC 29646, USA.
Jessica M DavisGreenwood Genetic Center, Greenwood, SC 29646, USA.
A Micheil InnesDepartments of Medical Genetics and Pediatrics, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada.
Xing-Chang WeiDepartment of Diagnostic Imaging, Cumming School of Medicine, University of Calgary, AB T2N 4N1, Canada.
Boris KerenDépartement de Génétique, Hôpital Pitié-Salpêtrière, Paris 75013, France.
Cyril MignotDépartement de Génétique, Hôpital Pitié-Salpêtrière, Paris 75013, France.
Robert Roger LebelDivision of Development, Behavior, and Genetics, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Steven M SperberDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Ai SakonjuDepartment of Neurology, Upstate Health Care Center, Syracuse, NY 13210, USA.
Nienke DosaDivision of Development, Behavior, and Genetics, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Daniela Q C M Barge-SchaapveldDepartment of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.
Cacha M P C D Peeters-ScholteDepartment of Neurology, Leiden University Medical Center, 2333 Leiden, the Netherlands.
Claudia A L RuivenkampDepartment of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.
Bregje W van BonDepartment of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen 6525, the Netherlands.
Joanna KennedyUniversity Hospital Bristol, NHS Foundation Trust, Bristol BS1 3NU, UK.
Karen J LowUniversity Hospital Bristol, NHS Foundation Trust, Bristol BS1 3NU, UK.
Sian EllardExeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Lewis PangExeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Joseph J JunewickDepartment of Radiology, Helen DeVos Children's Hospital, Grand Rapids, MI 49503, USA.
Paul R MarkSpectrum Health Medical Genetics, Grand Rapids, MI 49503, USA.
Gemma L CarvillDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Geoffrey T SwansonDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: gtswanson@northwestern.edu.
Northwestern University · USSUNY Upstate Medical University · USGreenwood Genetic Center · USLeiden University Medical Center · NLRadboud University Nijmegen · NLTartu University Hospital · EERoyal Devon & Exeter NHS Foundation Trust · GBSorbonne Université · FRTallinn Health Care College · EEThe University of Melbourne · AUUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity Medical Center Groningen · NLUniversity of Calgary · CAHelen DeVos Children's Hospital · USMurdoch Children's Research Institute · AUSpectrum Health · USSydney Children's Hospital · AUUNSW Sydney · AU

Funding

Deciphering the Roles of Kainate Receptors in Developing CNS CircuitsR01NS105502 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CONTRACTOR, ANIS, SWANSON, GEOFFREY T · 2018 to 2022
$2.6M
An epigenomic approach to identifying noncoding mutations in epilepsyR00NS089858 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CARVILL, GEMMA LOUISE · 2016 to 2018
$744k
NINDS NIH HHS R00 NS089858NINDS NIH HHS R01 NS105502
6 · The paper itself

Abstract

Kainate receptors (KARs) are glutamate-gated cation channels with diverse roles in the central nervous system. Bi-allelic loss of function of the KAR-encoding gene GRIK2 causes a nonsyndromic neurodevelopmental disorder (NDD) with intellectual disability and developmental delay as core features. The extent to which mono-allelic variants in GRIK2 also underlie NDDs is less understood because only a single individual has been reported previously. Here, we describe an additional eleven individuals with heterozygous de novo variants in GRIK2 causative for neurodevelopmental deficits that include intellectual disability. Five children harbored recurrent de novo variants (three encoding p.Thr660Lys and two p.Thr660Arg), and four children and one adult were homozygous for a previously reported variant (c.1969G>A [p.Ala657Thr]). Individuals with shared variants had some overlapping behavioral and neurological dysfunction, suggesting that the GRIK2 variants are likely pathogenic. Analogous mutations introduced into recombinant GluK2 KAR subunits at sites within the M3 transmembrane domain (encoding p.Ala657Thr, p.Thr660Lys, and p.Thr660Arg) and the M3-S2 linker domain (encoding p.Ile668Thr) had complex effects on functional properties and membrane localization of homomeric and heteromeric KARs. Both p.Thr660Lys and p.Thr660Arg mutant KARs exhibited markedly slowed gating kinetics, similar to p.Ala657Thr-containing receptors. Moreover, we observed emerging genotype-phenotype correlations, including the presence of severe epilepsy in individuals with the p.Thr660Lys variant and hypomyelination in individuals with either the p.Thr660Lys or p.Thr660Arg variant. Collectively, these results demonstrate that human GRIK2 variants predicted to alter channel function are causative for early childhood development disorders and further emphasize the importance of clarifying the role of KARs in early nervous system development.

Indexed as

MutationAdolescentAdultAllelesBrainChildChild, PreschoolDevelopmental DisabilitiesEpilepsyEvoked PotentialsGene Expression Regulation, DevelopmentalGenetic Association StudiesGluK2 Kainate ReceptorHeterozygoteHomozygoteHumansGluK2 Kainate ReceptorKainic Acid Receptorsataxiachannel gatingelectrophysiologyepilepsyGluK2glutamate receptorintellectual disabilitywhite matter abnormalitieswhole-exome sequencing

Identifiers

PMID34375587
PMCPMC8456161
OpenAlexW3188534469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.